ACI's 31st Annual Conference on Drug & Medical Device Litigation

Morgan Lewis litigation partner Evan Jacobs and of counsel Maureen Barber will speak at the American Conference Institute’s (ACI’s) 31st Annual Conference on Drug and Medical Device Litigation.

Artificial Intelligence Litigation Showcase: AI and Accompanying Tools That are Rapidly Transforming the Life Sciences Product Liability Sector
Evan K. Jacobs | Partner, Philadelphia
Wednesday, December 2, 2026 | 2:00 pm ET

This panel will examine how AI is transforming litigation strategies, case management, and trial preparation in drug and medical device product liability matters. Topics will include exploring emerging AI tools for document and medical record review, motion and brief development, oral argument preparation, and trial demonstrations; identifying creative ways to improve litigation efficiency; addressing risks associated with AI-assisted legal representation and privilege; navigating judicial oversight and disclosure requirements; and understanding how litigators can use AI effectively while avoiding ethical and compliance pitfalls.

One-Year Update on Rule 16.1: Bench and Litigant Approaches to the Different Stages of MDL Matters
Maureen K. Barber | Of Counsel, Pittsburgh
Wednesday, December 2, 2026 | 3:00 pm ET

This panel will discuss the impact of Federal Rule of Civil Procedure 16.1, which took effect in December 2025, on case management practices and judicial discretion in MDL proceedings. Topics will include examining how courts have applied the new rule, exploring its permissive rather than mandatory provisions, assessing its implications for judicial discretion and early case management, evaluating its potential to address meritless mass filings, and considering whether its nonbinding language may perpetuate uncertainty in MDL proceedings.